Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Toxicol Pathol. 2012 Nov 28;41(5):744–760. doi: 10.1177/0192623312464308

Figure 5.

Figure 5

Morphometric quantitation of MSA immunolabelling as a measure of stellate cell myofibroblastictrans differentiation. Relationship between phenotype and the area percentage occupied by the MSA immunostained cells.